{"product_id":"penn-medicine-state-of-art-heart-failure-course-2022","title":"Penn Medicine State of Art Heart Failure Course 2022","description":"\u003ch1 class=\"product_title entry-title\"\u003ePenn Medicine State of Art Heart Failure Course 2022\u003c\/h1\u003e\n\u003cp class=\"product_title entry-title\"\u003ePenn Medicine State of Art Heart Failure Course 2022\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Include: 31 videos + 33 pdfs, size: 11.3 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: internist, cardiologist, surgeon, family medicine physician\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Sample video: \u003cspan style=\"color: #0000ff\"\u003e\u003ca style=\"color: #0000ff\" href=\"https:\/\/medustudent.com\/contact_us\/\"\u003econtact me\u003c\/a\u003e \u003c\/span\u003efor sample video\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eDate \u0026amp; Location\u003c\/strong\u003e\u003c\/div\u003e\n\u003cp\u003eFriday, October 21, 2022, 8:30 AM – Saturday, October 22, 2022, 6:30 PM, Arthur H. Rubenstein Auditorium, Smilow Center for Translational Research and On-Line (Hybrid), Philadelphia, PA\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cp\u003ePenn Medicine State of Art Heart Failure Course 2022\u003c\/p\u003e\n\u003cp\u003eThis course will provide a comprehensive, state of the art update on the management of heart failure focusing on the recently updated ACC\/AHA Heart Failure Management Guidelines. The course is divided into six threads each focusing on a unique aspect of heart failure management from medical and device therapies, recognition of unique etiologies of heart failure, management of cardiogenic shock and selection for advanced therapies including transplant and ventricular assist devices. Each thread will have one or more cases to illustrate diagnostic and therapeutic challenges followed by panel discussions and audience participation to make the material actionable in daily practice.\u003c\/p\u003e\n\u003cp\u003eTwo keynote speakers, one each day, will provide a visionary overview of the days’ topics and provide valuable perspective from a thought leader. A unique aspect of this course will be a mock patient selection committee meeting for heart transplant and ventricular assist device to include a representative of each of the disciplines present during these life and death deliberations.\u003c\/p\u003e\n\u003cp\u003eThis will be an opportunity to see, first hand, how patients are presented and which clinical and psychosocial aspects are considered in advanced therapy patient selection. The program includes a debate as well as a presentation from a patient who had a ventricular assist device and went on to have a heart transplant. The faculty will include heart failure cardiologists, interventional cardiologists, cardiothoracic surgeons, electrophysiologists, advanced practice providers, social workers, a patient and other members of the Heart Team.\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003ePenn Medicine \u003c\/em\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – EMERGENCY MEDICINE – Internal Medicine-Critical Care Medicine, FAMILY MEDICINE, FAMILY MEDICINE – Geriatric Medicine, INTERNAL MEDICINE, INTERNAL MEDICINE – Advanced Heart Failure and Transplant Cardiology, INTERNAL MEDICINE – Clinical Cardiac Electrophysiology, INTERNAL MEDICINE – Geriatric Medicine, INTERNAL MEDICINE – Hospice and Palliative Medicine, INTERNAL MEDICINE – Interventional Cardiology, MEDICAL GENETICS AND GENOMICS – Medical Biochemical Genetics, THORACIC AND CARDIAC SURGERY\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cem\u003eAfter completing this activity, participants should be able to:\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe evidence based therapies for the treatment of heart failure including SGLT-2 inhibitors and soluable guanylate cyclase activators\u003c\/li\u003e\n\u003cli\u003eExplain how to increase the percent of patients with heart failure with reduced ejection fraction receiving all 4 guideline directed classes of medications\u003c\/li\u003e\n\u003cli\u003eDescribe evidence based therapies for hypertrophic cardiomyopathy and amyloid cardiomyopathy\u003c\/li\u003e\n\u003cli\u003eExplain the indications for TAVR and mitral valve edge to edge repairs\u003c\/li\u003e\n\u003cli\u003eExplain the indications for remote monitoring of heart failure patients\u003c\/li\u003e\n\u003cli\u003eFormulate appropriate approaches to overcoming barriers to achieving heart failure guideline directed medical and device therapies\u003c\/li\u003e\n\u003cli\u003eIdentify patients who may benefit from cardiac contractility management, biventricular pacing and ICD’s\u003c\/li\u003e\n\u003cli\u003eDescribe patient characteristics that are associated with improved outcomes following revascularization procedures\u003c\/li\u003e\n\u003cli\u003eIdentify evidence based therapies for heart failure with preserved ejection fraction\u003c\/li\u003e\n\u003cli\u003eDescribe the impact of COVID-19 on the heart\u003c\/li\u003e\n\u003cli\u003eExplain the mechanisms of action and cardiac risks of cancer chemotherapeutic agents\u003c\/li\u003e\n\u003cli\u003eIdentify clinical, laboratory, imaging and psychosocial factors that predict outcome in heart transplant and ventricular assist devices\u003c\/li\u003e\n\u003cli\u003eDescribe the use of genetic testing in identifying genetic causes of cardiomyopathy\u003c\/li\u003e\n\u003cli\u003eIdentify when to refer a patient to a multidisciplinary heart failure program\u003c\/li\u003e\n\u003cli\u003eDescribe the roles and responsibilities of members of the interprofessional heart failure team\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003ePenn Medicine\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAcute Shock and Shock Team.mp4\u003c\/li\u003e\n\u003cli\u003eAcute Shock and Shock Team.pdf\u003c\/li\u003e\n\u003cli\u003eAdvanced Therapies Selection Meeting ‘The Chosen Ones’.mp4\u003c\/li\u003e\n\u003cli\u003eAdvanced Therapies Selection Meeting ‘The Chosen Ones’.pdf\u003c\/li\u003e\n\u003cli\u003eAmyloid – ‘Gumming up the Works’.mp4\u003c\/li\u003e\n\u003cli\u003eAmyloid – ‘Gumming up the Works’.pdf\u003c\/li\u003e\n\u003cli\u003eCardiac Effects of COVID – ‘Pandemic Palpitations’.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac Effects of COVID – ‘Pandemic Palpitations’.pdf\u003c\/li\u003e\n\u003cli\u003eCardio-Oncology ‘Good Drugs Gone Bad’.mp4\u003c\/li\u003e\n\u003cli\u003eCardio-Oncology ‘Good Drugs Gone Bad’.pdf\u003c\/li\u003e\n\u003cli\u003eCase 1.mp4\u003c\/li\u003e\n\u003cli\u003eCase 1.pdf\u003c\/li\u003e\n\u003cli\u003eCase 2.mp4\u003c\/li\u003e\n\u003cli\u003eCase 2.pdf\u003c\/li\u003e\n\u003cli\u003eCase 3.mp4\u003c\/li\u003e\n\u003cli\u003eCase 3.pdf\u003c\/li\u003e\n\u003cli\u003eCase 4.mp4\u003c\/li\u003e\n\u003cli\u003eCase 4.pdf\u003c\/li\u003e\n\u003cli\u003eComorbidites in Heart Failure.mp4\u003c\/li\u003e\n\u003cli\u003eComorbidites in Heart Failure.pdf\u003c\/li\u003e\n\u003cli\u003eDebate – VAD Outcomes are as Good as Heart Transplant ‘It’s a Wash’.pdf\u003c\/li\u003e\n\u003cli\u003eDebate – VAD Outcomes are as Good as Heart Transplant “It’s a Wash”.mp4\u003c\/li\u003e\n\u003cli\u003eDebate – VAD Outcomes are as Good as Heart Transplant “It’s a Wash”.pdf\u003c\/li\u003e\n\u003cli\u003eDevices to Help the Failing Heart – ‘Just a Lttle Clip’.mp4\u003c\/li\u003e\n\u003cli\u003eDevices to Help the Failing Heart – ‘Just a Lttle Clip’.pdf\u003c\/li\u003e\n\u003cli\u003eEP and Heart Failure – ‘Keeping the Beat’.mp4\u003c\/li\u003e\n\u003cli\u003eEP and Heart Failure – ‘Keeping the Beat’.pdf\u003c\/li\u003e\n\u003cli\u003eGenetic Dilated Cardimyopathy – ‘It’s in the Genes’.pdf\u003c\/li\u003e\n\u003cli\u003eHeart Transplant – ‘Change of Heart’.mp4\u003c\/li\u003e\n\u003cli\u003eHeart Transplant – ‘Change of Heart’.pdf\u003c\/li\u003e\n\u003cli\u003eHF22_Brochure_v13.pdf\u003c\/li\u003e\n\u003cli\u003eHFpEF – Finally Something to do.pdf\u003c\/li\u003e\n\u003cli\u003eHypertrophic Cardiomyopathy.pdf\u003c\/li\u003e\n\u003cli\u003eKeynote- Cardiogenic Shock- Principles, Progress and Future Prospects.mp4\u003c\/li\u003e\n\u003cli\u003eKeynote- Cardiogenic Shock- Principles, Progress and Future Prospects.pdf\u003c\/li\u003e\n\u003cli\u003eKEYNOTE- The New AHA ACC HFSA Heart Failure Guidelines.mp4\u003c\/li\u003e\n\u003cli\u003eKEYNOTE- The New AHA ACC HFSA Heart Failure Guidelines.pdf\u003c\/li\u003e\n\u003cli\u003eLiving with Heart Failure (or MCS or Transplant) – ‘No Pulse No Problem’.mp4\u003c\/li\u003e\n\u003cli\u003eLiving with Heart Failure (or MCS or Transplant) – ‘No Pulse No Problem’.pdf\u003c\/li\u003e\n\u003cli\u003eMechanical Circulatory Support – ‘Go with the Continuous Flow’.mp4\u003c\/li\u003e\n\u003cli\u003eMechanical Circulatory Support – ‘Go with the Continuous Flow’.pdf\u003c\/li\u003e\n\u003cli\u003eNew Heart Failure Guidelines.mp4\u003c\/li\u003e\n\u003cli\u003eNew Heart Failure Guidelines.pdf\u003c\/li\u003e\n\u003cli\u003eNew Technologies That Might Just Work.mp4\u003c\/li\u003e\n\u003cli\u003eNew Technologies That Might Just Work.pdf\u003c\/li\u003e\n\u003cli\u003eNovel Drugs.mp4\u003c\/li\u003e\n\u003cli\u003eNovel Drugs.pdf\u003c\/li\u003e\n\u003cli\u003eOvercoming Barriers to Advanced Therapies.mp4\u003c\/li\u003e\n\u003cli\u003eOvercoming Barriers to Advanced Therapies.pdf\u003c\/li\u003e\n\u003cli\u003ePanel Discussion with Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003ePulmonary Hypertension and Right Ventricular Failure.mp4\u003c\/li\u003e\n\u003cli\u003ePulmonary Hypertension and Right Ventricular Failure.pdf\u003c\/li\u003e\n\u003cli\u003eRemote Monitoring – ‘Keeping my eye on you’.mp4\u003c\/li\u003e\n\u003cli\u003eRemote Monitoring – ‘Keeping my eye on you’.pdf\u003c\/li\u003e\n\u003cli\u003eRevascularization.mp4\u003c\/li\u003e\n\u003cli\u003eRevascularization.pdf\u003c\/li\u003e\n\u003cli\u003eSarcoid – ‘My Heart is on Fire’.mp4\u003c\/li\u003e\n\u003cli\u003eSarcoid – ‘My Heart is on Fire’.pdf\u003c\/li\u003e\n\u003cli\u003eSGLT-2 Inhibitors and Vericiguat ‘How Sweet it is!’.mp4\u003c\/li\u003e\n\u003cli\u003eSGLT-2 Inhibitors and Vericiguat ‘How Sweet it is!’.pdf\u003c\/li\u003e\n\u003cli\u003eSystolic Heart Failure – How to Achieve Myocardial Recovery Panel Discussion with Q\u0026amp;A 1.mp4\u003c\/li\u003e\n\u003cli\u003eSystolic Heart Failure – How to Achieve Myocardial Recovery Panel Discussion with Q\u0026amp;A 2.mp4\u003c\/li\u003e\n\u003cli\u003eValve Surgery.mp4\u003c\/li\u003e\n\u003cli\u003eValve Surgery.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954634395746,"sku":"MED-AMB07227","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Penn-Medicine-State-of-Art-Heart-Failure-Course-2022.jpg?v=1779381285","url":"https:\/\/meducourse.com\/products\/penn-medicine-state-of-art-heart-failure-course-2022","provider":"Meducourse","version":"1.0","type":"link"}